News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

This article was first published 3 years ago
Home  » News » Gujarat gets lion's share of Covid vaccines

Gujarat gets lion's share of Covid vaccines

By Ruchika Chitravanshi and Sohini Das
May 04, 2021 10:11 IST
Get Rediff News in your Inbox:

Delhi, which has been one of the worst affected states, accounted for less than two per cent of total vaccinations in the 18-44 age-group.
Ruchika Chitravanshi and Sohini Das report.

IMAGE: A healthcare worker gives a dose of the Covishield caccine to a woman inside a classroom of a school, which has been converted into a temporary vaccination centre, in Ahmedabad, May 1, 2021. Photograph: Amit Dave/Reuters
 

Since the much-awaited universal vaccination for all adults started in India on May 1, over 200,000 have received the jab in the 18-44 age group.

Health ministry data shows a huge disparity in the doses that were given in just eleven states which could launch the drive on May 1 due to paucity of supply.

Gujarat got the lion's share with 60 per cent doses given on day one.

Delhi, which has been one of the worst affected states, accounted for less than two per cent of total vaccinations in the said age-group.

States are now free to negotiate and procure vaccines directly from the manufacturers.

Some, including senior Congress leader Jairam Ramesh, have raised this disparity and also why only a few states could provide the life-saving shot on May 1.

 

The health ministry has said that its major focus continues to be the 45 plus age group which is the most vulnerable to the disease, according to its data.

The 18-44 group is an additionality.

The government expects this phase to stabilise and reach a wider population in a few weeks, but the main challenge remains -- insufficient stock.

Feature Presentation: Ashish Narsale/Rediff.com

Get Rediff News in your Inbox:
Ruchika Chitravanshi and Sohini Das
Source: source
 
Jharkhand and Maharashtra go to polls

Two states election 2024